Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9

American Journal of Surgery

Volumn 208, Issue 6, 2014, Pages 954-960

  Wiggins Dohlvik, Katie ^a,b   Merriman, Morgan ^a,b   Shaji, Chinchusha A ^a,b   Alluri, Himakarnika ^a,b   Grimsley, Marcene ^a,b   Davis, Matthew L ^a,b   Smith, Randall W ^a,b   Tharakan, Binu ^a,b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Caspase 3; Gelatinase B; Matrix metalloproteinase; Traumatic brain injury; Tumor necrosis factor

Indexed keywords

CASPASE 3; F ACTIN; GELATINASE B; MATRIX METALLOPROTEINASE 9 INHIBITOR 1; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TJP1 PROTEIN, HUMAN;

ACTIN POLYMERIZATION; ANIMAL CELL; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; BRAIN; CAPILLARY ENDOTHELIAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FILAMENTOUS ACTIN STRESS FIBER; IMMUNOFLUORESCENCE; IN VITRO STUDY; NONHUMAN; RAT; STRESS FIBER; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURY; CELL CULTURE; CYTOLOGY; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN INJURIES; CASPASE 3; CELLS, CULTURED; ENDOTHELIAL CELLS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; RATS; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84916631758     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2014.08.014     Document Type: Conference Paper

References (28)

1. V.G. Coronado, L.C. McGuire, and K. Sarmiento Trends in Traumatic Brain Injury in the U.S. and the public health response: 1995-2009 J Safety Res 43 2012 299 307
2. CDC National Hospital Discharge Survey and National Hospital Ambulatory Medical Care Survey. National Center for Health Statistics 2010 CDC Available at: http://www.cdc.gov/traumaticbraininjury/data/
3. S. Okie Traumatic brain injury in the war zone N Engl J Med 352 2005 2043 2047
4. J.M. Hardman, and A. Manoukian Pathology of head trauma Neuroimaging Clin N Am 12 2002 175 187 vii
5. J.E. Risdall, and D.K. Menon Traumatic brain injury Philos Trans R Soc 366 2011 241 250
6. S.H. Haddah, and Y.M. Arabi Critical care management of severe traumatic brain injury in adults Scand J Trauma Resusc Emerg Med 20 2012 12
7. S.C. Hellewell, and M.C. Morganti-Kossmann Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury Mediators Inflamm 2012 2012 1 18
8. G. Cheng, R. Kong, and L. Zhang Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies Br J Pharmacol 167 2012 699 719
9. A.G. Mustafa, and O.A. Al-Shboul Pathophysiology of traumatic brain injury Neurosciences 18 2013 222 234
10. H. Algattas, and J.B. Huang Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injury Int J Mol Sci 15 2014 309 341
11. J.T. Weber Altered calcium signaling following traumatic brain injury Front Pharmacol 3 2012 1 16
12. A.W. Unterberg, J. Stover, and B. Kress Edema and brain trauma Neuroscience 129 2004 1021 1029
13. K. Fluiter, A.L. Opperhuizen, and B.P. Morgan Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice J Immunol 192 2014 2339 2348
14. P.B.L. Pun, J. Lu, and S. Moochhala Involvement of ROS in BBB dysfunction Free Radic Res 43 2009 348 364
15. M. Khan, Y.B. Im, and A. Shunmugavel Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact J Neuroinflammation 6 2009 1 12
16. O. Hadass, B.N. Tomlinson, and M. Gooyit Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury PLoS One 8 2013 e76904
17. Y. Yang, E.Y. Estrada, and J.F. Thompson Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat J Cereb Blood Flow Metab 27 2007 697 709
18. L.B. Qiu, Y. Zhou, and Q. Wang Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats Toxicology 285 2011 31 38
19. C.L. Tsai, W.C. Chen, and H.L. Hsieh TNF-alpha induces matrix metalloproteinase-9- dependent soluble intercellular adhesion molecule-1 release via TRAF2-mediated MAPKs and NF- B activation in osteoblast-like MC3T3-E1 cells J Biomed Sci 21 2014 1 19
20. H. Yamada, M. Yoneda, and S. Inaguma Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium Biochem Pharmacol 85 2013 1770 1782
21. I.T. Lee, C.C. Lin, and Y.C. Wu TNF-a induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCa-dependent signaling pathways J Cell Physiol 224 2010 454 464
22. W. Li, H. Li, and A.D. Bocking Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway Biol Reprod 83 2010 481 487
23. Y. Lin, and L. Wen Inflammatory response following diffuse axonal injury Int J Med Sci 10 2012 515 521
24. P.M. Lenzlinger, M.C. Morganti-Kossman, and H.L. Laurer The duality of the inflammatory response to traumatic brain injury Mol Neurobiol 24 2001 169 181
25. P.D. Vermeer, J. Denker, and M. Estin MMP9 modulates tight junction integrity and cell viability in human airway epithelia Am J Physiol Lung Cell Mol Physiol 296 2009 L751 L762
26. K. Sriram, and J.P. O'Callaghan Divergent roles for tumor necrosis factor J Neuroimmune Pharmacol 2 2007 140 153
27. P.G. Sullivan, A.J. Bruce-Keller, and A.G. Rabchevsky Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury J Neurosci 19 1999 6248 6256
28. J.E. Kim, H.J. Ryu, and T.C. Kang P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-a-mediated pathway in the rat hippocampus following status epilepticus J Neuroinflammation 8 2011 1 12